Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
If the solution is cloudy or contains visible particles, it may indicate a problem with solubility, contamination, or that the peptide has been damaged
it is not a dosing recommendation
These changes can sometimes trigger inflammation, which is a key factor in acne development
"Effect of bile on vitamin B12 absorption"
For researchers building broader peptide knowledge, the complete guide to peptides provides essential foundational context